Display options
Share it on

Front Syst Neurosci. 2012 Nov 30;6:77. doi: 10.3389/fnsys.2012.00077. eCollection 2012.

Biological sources of inflexibility in brain and behavior with aging and neurodegenerative diseases.

Frontiers in systems neuroscience

S Lee Hong, George V Rebec

Affiliations

  1. Department of Biomedical Sciences, Ohio University Athens, OH, USA.

PMID: 23226117 PMCID: PMC3510451 DOI: 10.3389/fnsys.2012.00077

Abstract

Almost unequivocally, aging and neurodegeneration lead to deficits in neural information processing. These declines are marked by increased neural noise that is associated with increased variability or inconsistency in behavioral patterns. While it is often viewed that these problems arise from dysregulation of dopamine (DA), a monoamine modulator, glutamate (GLU), an excitatory amino acid that interacts with DA, also plays a role in determining the level of neural noise. We review literature demonstrating that neural noise is highest at both high and low levels of DA and GLU, allowing their interaction to form a many-to-one solution map for neural noise modulation. With aging and neurodegeneration, the range over which DA and GLU can be modulated is decreased leading to inflexibility in brain activity and behavior. As the capacity to modulate neural noise is restricted, the ability to shift noise from one brain region to another is reduced, leading to greater uniformity in signal-to-noise ratios across the entire brain. A negative consequence at the level of behavior is inflexibility that reduces the ability to: (1) switch from one behavior to another; and (2) stabilize a behavioral pattern against external perturbations. In this paper, we develop a theoretical framework where inflexibility across brain and behavior, rather than inconsistency and variability is the more important problem in aging and neurodegeneration. This theoretical framework of inflexibility in aging and neurodegeneration leads to the hypotheses that: (1) dysfunction in either or both of the DA and GLU systems restricts the ability to modulate neural noise; and (2) levels of neural noise and variability in brain activation will be dedifferentiated and more evenly distributed across the brain; and (3) changes in neural noise and behavioral variability in response to different task demands and changes in the environment will be reduced.

Keywords: aging; dopamine; glutamates; neural noise; neurodegenerative diseases

References

  1. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13763-8 - PubMed
  2. Trends Cogn Sci. 2001 Nov 1;5(11):479-486 - PubMed
  3. Neuroscience. 2011 Dec 15;198:3-18 - PubMed
  4. Nonlinear Dynamics Psychol Life Sci. 2010 Jul;14(3):291-315 - PubMed
  5. J Appl Physiol (1985). 1997 Jan;82(1):262-9 - PubMed
  6. Arch Ital Biol. 2010 Sep;148(3):323-37 - PubMed
  7. Mech Ageing Dev. 2001 Jan;122(1):1-29 - PubMed
  8. J Gerontol B Psychol Sci Soc Sci. 2004 Mar;59(2):P49-55 - PubMed
  9. Int J Geriatr Psychiatry. 2002 Apr;17(4):359-70 - PubMed
  10. Chaos. 2008 Mar;18(1):013108 - PubMed
  11. JAMA. 1992 Apr 1;267(13):1806-9 - PubMed
  12. Behav Brain Funct. 2010 Apr 23;6:24 - PubMed
  13. Behav Brain Res. 2009 Aug 24;202(1):130-7 - PubMed
  14. Front Biosci (Elite Ed). 2012 Jan 01;4:976-97 - PubMed
  15. Nat Rev Drug Discov. 2009 Jan;8(1):17-8 - PubMed
  16. Commun Integr Biol. 2012 May 1;5(3):259-61 - PubMed
  17. Neuroscience. 1996 Oct;74(3):741-56 - PubMed
  18. PLoS One. 2012;7(1):e30879 - PubMed
  19. Neurosci Biobehav Rev. 2002 Nov;26(7):795-808 - PubMed
  20. J Neurophysiol. 2008 Oct;100(4):2205-16 - PubMed
  21. Clin Neurophysiol. 2004 Feb;115(2):267-81 - PubMed
  22. Nature. 1998 Aug 20;394(6695):780-4 - PubMed
  23. Nat Med. 2009 Dec;15(12):1407-13 - PubMed
  24. Clin Geriatr Med. 2011 Nov;27(4):629-44 - PubMed
  25. J Comp Neurol. 2008 Dec 1;511(4):421-37 - PubMed
  26. Neurochem Int. 2004 Oct;45(5):583-95 - PubMed
  27. Int J Neural Syst. 1994 Jun;5(2):83-6 - PubMed
  28. J Neurosci. 2006 Aug 2;26(31):8148-59 - PubMed
  29. Arch Neurol. 2009 Oct;66(10):1202-8 - PubMed
  30. Neuropsychology. 2005 Jan;19(1):88-96 - PubMed
  31. Psychol Rev. 1979 Sep;47(5):415-51 - PubMed
  32. Prog Neurobiol. 2007 Apr;81(5-6):253-71 - PubMed
  33. Nat Rev Neurosci. 2008 Apr;9(4):292-303 - PubMed
  34. J Neurosci. 2011 Mar 23;31(12):4496-503 - PubMed
  35. Biol Psychiatry. 1995 Nov 15;38(10):669-76 - PubMed
  36. Neurobiol Aging. 2002 Jan-Feb;23(1):1-11 - PubMed
  37. J Neural Transm (Vienna). 2011 Dec;118(12):1659-60 - PubMed
  38. Brain Res Brain Res Rev. 2000 Mar;31(2-3):330-41 - PubMed
  39. PLoS One. 2010 Jul 07;5(7):e11461 - PubMed
  40. Exp Brain Res. 1998 Dec;123(3):255-62 - PubMed
  41. Biomed Eng Online. 2007 Jun 26;6:23 - PubMed
  42. Psychon Bull Rev. 2002 Dec;9(4):672-705 - PubMed
  43. J Gerontol. 1992 Sep;47(5):P344-9 - PubMed
  44. Parkinsonism Relat Disord. 2008;14(4):273-80 - PubMed
  45. Nat Rev Neurosci. 2012 Mar 07;13(4):240-50 - PubMed
  46. Basal Ganglia. 2012 Jul 1;2(2):57-66 - PubMed
  47. Cereb Cortex. 2011 Sep;21(9):2023-32 - PubMed
  48. J Gerontol A Biol Sci Med Sci. 2002 Mar;57(3):B115-25 - PubMed
  49. Synapse. 1997 Nov;27(3):242-61 - PubMed
  50. Neuroscience. 2008 Apr 22;153(1):329-37 - PubMed
  51. Nat Med. 2011 Dec 18;18(1):153-8 - PubMed
  52. Behav Brain Res. 2002 Dec 2;137(1-2):47-63 - PubMed
  53. Neurosci Biobehav Rev. 1997 Jul;21(4):437-46 - PubMed
  54. Chaos. 2008 Sep;18(3):033131 - PubMed
  55. J Gen Physiol. 2001 May;117(5):491-504 - PubMed
  56. Exp Gerontol. 1986;21(3):159-68 - PubMed
  57. Neurosci Biobehav Rev. 2010 Apr;34(5):660-9 - PubMed
  58. Gerontol Clin (Basel). 1963;5:129-38 - PubMed
  59. J Neurosci. 2002 Oct 15;22(20):9134-41 - PubMed
  60. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2297-301 - PubMed
  61. J Neurochem. 2006 May;97(3):737-46 - PubMed
  62. Nat Neurosci. 2002 Apr;5(4):325-31 - PubMed
  63. Neurobiol Aging. 1991 Mar-Apr;12(2):93-8 - PubMed
  64. Arch Neurol. 1993 May;50(5):474-80 - PubMed
  65. Neuron. 2010 Jan 28;65(2):178-90 - PubMed
  66. Trends Cogn Sci. 2002 Oct 1;6(10):416-421 - PubMed
  67. Neuroscience. 1996 Aug;73(3):733-50 - PubMed
  68. J Cereb Blood Flow Metab. 1997 Mar;17(3):316-30 - PubMed
  69. Neurosci Lett. 2003 Sep 18;348(3):155-8 - PubMed
  70. CNS Neurosci Ther. 2010 Jun;16(3):163-78 - PubMed
  71. Nature. 2011 Jul 27;476(7359):210-3 - PubMed
  72. Nat Rev Neurosci. 2007 Dec;8(12):935-47 - PubMed
  73. Chaos. 1997 Mar;7(1):67-81 - PubMed
  74. Science. 2003 Mar 21;299(5614):1898-902 - PubMed
  75. Nat Rev Neurosci. 2011 Jun;12(6):359-66 - PubMed
  76. J Neural Transm Suppl. 1994;44:145-58 - PubMed
  77. Neurobiol Aging. 2011 Dec;32(12):2318.e17-30 - PubMed
  78. Trends Neurosci. 2007 May;30(5):194-202 - PubMed
  79. Neuroscience. 2006 Apr 28;139(1):263-76 - PubMed
  80. Neuroscience. 2010 Dec 29;171(4):1283-6 - PubMed
  81. J Anat. 2004 Dec;205(6):433-42 - PubMed
  82. J Neurosci. 2012 Jun 13;32(24):8186-91 - PubMed
  83. Behav Pharmacol. 2005 May;16(3):155-61 - PubMed
  84. Psychopharmacology (Berl). 1993;111(4):391-401 - PubMed
  85. Handb Clin Neurol. 2011;100:83-100 - PubMed
  86. Brain Res. 1993 Feb 26;604(1-2):334-7 - PubMed
  87. Apoptosis. 2009 Apr;14(4):478-500 - PubMed
  88. Psychoneuroendocrinology. 1996 Feb;21(2):173-87 - PubMed
  89. J Neurosci. 2010 Apr 7;30(14):4914-21 - PubMed
  90. Curr Biol. 2000 Jul 13;10(14):R509-11 - PubMed
  91. Mol Pharmacol. 1998 Feb;53(2):195-201 - PubMed
  92. J Exp Psychol. 1964 Feb;67:103-12 - PubMed
  93. Mov Disord. 1998 May;13(3):428-37 - PubMed
  94. Cogn Sci. 2006 Jan 2;30(1):3-41 - PubMed
  95. Nature. 2001 Mar 8;410(6825):277-84 - PubMed
  96. J Neurophysiol. 1996 Jan;75(1):142-53 - PubMed

Publication Types

Grant support